This is great news, prolongs life without any side effects. The technology being studied and targets here is called PARP, or poly (ADP-ribose) polymerase. The drug prevents cancer cells from repairing their own DNA, thus enhancing the potential of chemotherapy and radiation radiation therapy...
The Medical Quack .... by Barbara Duck
The Medical Quack
Tue, Jun 2 2009
Filed under: Filed under: Medically Related, Pharma/FDA News, personalized medicine, DNA, Health Care, Chemotherapy, Breast Cancer, Side Effects, Genentech, Research and Development, BiPar